Clinical trial
Single Dose Azithromycin in the Treatment of Adult Cholera
NCT00229944 · International Centre for Diarrhoeal Disease Research, Bangladesh, Other · Completed
Key facts
| NCT number | NCT00229944 |
|---|---|
| Title | Single Dose Azithromycin in the Treatment of Adult Cholera |
| Official title | Randomized, Double-Blind, Controlled Clinical Trial to Compare Efficacy of a Single Dose of Azithromycin Versus a Single Dose of Ciprofloxacin in the Treatment of Adults With Clinically Severe Cholera Due to V. Cholerae O1 or O139 |
| Lead sponsor | International Centre for Diarrhoeal Disease Research, Bangladesh, Other |
| Collaborators | Pfizer Industry Tufts Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cholera |
| Intervention type | Drug |
| Interventions | Azithromycin |
| Enrollment | 220 |
| Start date | Dec 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Sep 30, 2005 |
| Last update posted | Jul 21, 2006 |
| Countries | Bangladesh |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: